Literature DB >> 18468463

Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction.

Qizhi Tang1, Jason Y Adams, Cristina Penaranda, Kristin Melli, Eliane Piaggio, Evridiki Sgouroudis, Ciriaco A Piccirillo, Benoit L Salomon, Jeffrey A Bluestone.   

Abstract

The dynamics of CD4(+) effector T cells (Teff cells) and CD4(+)Foxp3(+) regulatory T cells (Treg cells) during diabetes progression in nonobese diabetic mice was investigated to determine whether an imbalance of Treg cells and Teff cells contributes to the development of type 1 diabetes. Our results demonstrated a progressive decrease in the Treg cell:Teff cell ratio in inflamed islets but not in pancreatic lymph nodes. Intra-islet Treg cells expressed reduced amounts of CD25 and Bcl-2, suggesting that their decline was due to increased apoptosis. Additionally, administration of low-dose interleukin-2 (IL-2) promoted Treg cell survival and protected mice from developing diabetes. Together, these results suggest intra-islet Treg cell dysfunction secondary to defective IL-2 production is a root cause of the progressive breakdown of self-tolerance and the development of diabetes in nonobese diabetic mice.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18468463      PMCID: PMC2394854          DOI: 10.1016/j.immuni.2008.03.016

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  62 in total

Review 1.  Genetic protection from the inflammatory disease type 1 diabetes in humans and animal models.

Authors:  J A Todd; L S Wicker
Journal:  Immunity       Date:  2001-09       Impact factor: 31.745

2.  Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes.

Authors:  Shelley Lindley; Colin M Dayan; Amanda Bishop; Bart O Roep; Mark Peakman; Timothy I M Tree
Journal:  Diabetes       Date:  2005-01       Impact factor: 9.461

Review 3.  Interleukin-2 deficient mice: a new model to study autoimmunity and self-tolerance.

Authors:  I Horak; J Löhler; A Ma; K A Smith
Journal:  Immunol Rev       Date:  1995-12       Impact factor: 12.988

4.  BCG vaccination prevents insulin-dependent diabetes mellitus (IDDM) in NOD mice after disease acceleration with cyclophosphamide.

Authors:  H Y Qin; B Singh
Journal:  J Autoimmun       Date:  1997-06       Impact factor: 7.094

5.  Multiple immuno-regulatory defects in type-1 diabetes.

Authors:  Anjli Kukreja; Giulia Cost; John Marker; Chenhui Zhang; Zhong Sun; Karen Lin-Su; Svetlana Ten; Maureen Sanz; Mark Exley; Brian Wilson; Steven Porcelli; Noel Maclaren
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

6.  Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes.

Authors:  S Sharif; G A Arreaza; P Zucker; Q S Mi; J Sondhi; O V Naidenko; M Kronenberg; Y Koezuka; T L Delovitch; J M Gombert; M Leite-De-Moraes; C Gouarin; R Zhu; A Hameg; T Nakayama; M Taniguchi; F Lepault; A Lehuen; J F Bach; A Herbelin
Journal:  Nat Med       Date:  2001-09       Impact factor: 53.440

7.  Combination therapy with sirolimus and interleukin-2 prevents spontaneous and recurrent autoimmune diabetes in NOD mice.

Authors:  Alex Rabinovitch; Wilma L Suarez-Pinzon; A M James Shapiro; Ray V Rajotte; Robert Power
Journal:  Diabetes       Date:  2002-03       Impact factor: 9.461

8.  Mapping of the IDDM locus Idd3 to a 0.35-cM interval containing the interleukin-2 gene.

Authors:  P Denny; C J Lord; N J Hill; J V Goy; E R Levy; P L Podolin; L B Peterson; L S Wicker; J A Todd; P A Lyons
Journal:  Diabetes       Date:  1997-04       Impact factor: 9.461

9.  Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc, and lck cooperate in hematopoietic cell proliferation.

Authors:  T Miyazaki; Z J Liu; A Kawahara; Y Minami; K Yamada; Y Tsujimoto; E L Barsoumian; R M Permutter; T Taniguchi
Journal:  Cell       Date:  1995-04-21       Impact factor: 41.582

10.  Where CD4+CD25+ T reg cells impinge on autoimmune diabetes.

Authors:  Zhibin Chen; Ann E Herman; Michael Matos; Diane Mathis; Christophe Benoist
Journal:  J Exp Med       Date:  2005-11-21       Impact factor: 14.307

View more
  371 in total

1.  A delicate balance: tweaking IL-2 immunotherapy.

Authors: 
Journal:  Nat Med       Date:  2012-02-06       Impact factor: 53.440

Review 2.  Mixed chimerism and split tolerance: mechanisms and clinical correlations.

Authors:  David P Al-Adra; Colin C Anderson
Journal:  Chimerism       Date:  2011 Oct-Dec

Review 3.  Historical overview of immunological tolerance.

Authors:  Ronald H Schwartz
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-04-01       Impact factor: 10.005

Review 4.  Interleukin-2 receptor signaling: at the interface between tolerance and immunity.

Authors:  Thomas R Malek; Iris Castro
Journal:  Immunity       Date:  2010-08-27       Impact factor: 31.745

5.  Epitope-specific regulatory CD4 T cells reduce virus-induced illness while preserving CD8 T-cell effector function at the site of infection.

Authors:  Jie Liu; Tracy J Ruckwardt; Man Chen; John D Nicewonger; Teresa R Johnson; Barney S Graham
Journal:  J Virol       Date:  2010-08-04       Impact factor: 5.103

Review 6.  Genetics, pathogenesis and clinical interventions in type 1 diabetes.

Authors:  Jeffrey A Bluestone; Kevan Herold; George Eisenbarth
Journal:  Nature       Date:  2010-04-29       Impact factor: 49.962

7.  Amplification of autoimmune response through induction of dendritic cell maturation in inflamed tissues.

Authors:  Kristin Melli; Rachel S Friedman; Ashley E Martin; Erik B Finger; Gang Miao; Gregory L Szot; Matthew F Krummel; Qizhi Tang
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

Review 8.  The Expanding Role of Natural Killer Cells in Type 1 Diabetes and Immunotherapy.

Authors:  Chris Fraker; Allison L Bayer
Journal:  Curr Diab Rep       Date:  2016-11       Impact factor: 4.810

Review 9.  Targeting Type 1 Diabetes: Selective Approaches for New Therapies.

Authors:  Daniel F Sheehy; Sean P Quinnell; Arturo J Vegas
Journal:  Biochemistry       Date:  2019-01-17       Impact factor: 3.162

Review 10.  The IL-2/IL-2R system: from basic science to therapeutic applications to enhance immune regulation.

Authors:  Allison L Bayer; Alberto Pugliese; Thomas R Malek
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.